PMC 4437467
Research where GHK-Cu's skin-research thread isn't relevant
During the meeting, the FDAs own scientists recommended against allowing compounding pharmacies to produce any of the seven peptides being considered due to a lack of evidence showing they are safe and effective
Vascular Effects Vascular effects include: Angiogenesis Promotion Through VEGF and bFGF expression at 1 nM concentration Improved Blood Vessel Integrity Through collagen and elastin synthesis in vessel walls SPARC Protein Release Released during injury stimulates vessel growth and repair Enhanced Microcirculation Improved blood flow to peripheral tissues Anticoagulation Properties Demonstrated effects on blood clotting factors Restored Blood Flow To damaged tissues enhancing healing capacity Injectable Dosing Protocols and Administration Injectable GHK-Cu protocols typically use carefully calibrated dosing based on decades of research and clinical experience
Sikiric P, Gojkovic S, Krezic I, Smoday IM, Kalogjera L, Zizek H, Oroz K, Vranes H, Vukovic V, Labidi M, Strbe S, Baketic Oreskovic L, Sever M, Tepes M, Knezevic M, Barisic I, Blagaic V, Vlainic J, Dobric I, Staresinic M, Skrtic A, Jurjevic I, Boban Blagaic A, Seiwerth S
Umehara M, Ago Y, Kawanai T, Fujita K, Hiramatsu N, Takuma K, et al
